Mostrar el registro sencillo del ítem
dc.contributor.author
Galigniana, Mario Daniel
dc.date.available
2021-06-11T14:28:14Z
dc.date.issued
2013-12
dc.identifier.citation
Galigniana, Mario Daniel; Steroid-dependent management of biological responses in the nervous system; Bentham Science Publishers; Cns & Neurological Disorders-drug Targets; 12; 8; 12-2013; 1143-1145
dc.identifier.issn
1871-5273
dc.identifier.uri
http://hdl.handle.net/11336/133684
dc.description.abstract
The existence of corticosteroid receptors in the nervous system was first demonstrated in several structures such as the hypothalamus, hippocampus and the parietal cortex for a comprehensive review of that time whose validity still persists today). The potential presence of more than one population of corticosteroid-binding sites in the brain and in anterior pituitary was then suggested based on the differential binding of dexamethasone and corticosterone . These results were also consistent with the view that the dexamethasone blockade of stress-induced adrenocorticotrophic hormone release is mediated by the anterior pituitary, while the high specificity of corticosterone binding in the hippocampus implies a specific, but undetermined effect of the hormone in this brain area, an effect which was thought to be unrelated to regulation of adrenocorticotrophic hormone secretion. These findings led researchers to suggest a role of extrahypothalamic regions in the perception of corticosteroid feedback as well as in the regulation of the hypothalamo-hypophysial-adrenal function.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Bentham Science Publishers
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
ESTEROIDS
dc.subject
NERVOUS SYSTEM
dc.subject
NEURONS
dc.subject.classification
Neurociencias
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Steroid-dependent management of biological responses in the nervous system
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2021-06-07T16:56:11Z
dc.journal.volume
12
dc.journal.number
8
dc.journal.pagination
1143-1145
dc.journal.pais
Estados Unidos
dc.description.fil
Fil: Galigniana, Mario Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina
dc.journal.title
Cns & Neurological Disorders-drug Targets
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.eurekaselect.com/node/115022/article
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/ 10.2174/187152731131200127
Archivos asociados